Monday, August 26, 2019

Ray of hope for terminally-ill patients as new norms may allow use of experimental drugs

Ray of hope for terminally-ill patients as new norms may allow use of experimental drugs Currently, patients can use only those drugs which are approved by the drug regulator after it has passed clinical trials and found safe and efficacious, a process that takes several years. However, a new policy in the works will allow them to access pre-approval drugs in cases of serious and life-threatening diseases on compassionate grounds, without clearing clinical trials.

from Moneycontrol Business News https://ift.tt/2KVOaWm

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...